Atlas Trials

Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration

Clinical trial NCT00304954 · COMPLETED

Trial details

NCT number
NCT00304954
Sponsor
National Eye Institute (NEI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Age-Related Macular DegenerationChoroidal Neovascularization
Start date
2006-02-01
Primary completion
2010-01-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.